Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

By Gustafsson Ove   Mansour Essam   Norming Ulf   Carlsson Adelaida   Törnblom Magnus   Nyman Claes R.  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 6, 1998-12 ,pp. : 373-377

Informa Healthcare

Access to resources Recommend Favorite

Age-specific serum levels of complexed PSA (CPSA) for prostate cancer screening

By Bartsch G.   Cheli C.   Levine R.   Klocker H.   Horninger W.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 186-186

Elsevier

Access to resources Recommend Favorite

Color doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on gleason score for nonpalpable lesions

By Cornud F.   Belin X.   Piron D.   Chretien Y.   Flam T.   Casanova J.M.   Helenon O.   Mejean A.   Thiounn N.   Moreau J.F.  

Urology, Vol. 49, Iss. 5, 1997-05 ,pp. : 709-715

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free:total PSA ratios in a consecutive series of men referred for prostate biopsies

By Rydén Linda   Egevad Lars   Ekman Peter   Hellström Magnus  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 302-307

Informa Healthcare

Access to resources Recommend Favorite